Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Cipher Pharmaceuticals Reports Voting Results for the Election of Directors

Cipher Pharmaceuticals Inc.
Posted on: 11 May 18
Cipher Pharmaceuticals Reports Voting Results for the Election of Directors

Canada NewsWire

MISSISSAUGA, ON, May 11, 2018

MISSISSAUGA, ON, May 11, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company"), in accordance with Toronto Stock Exchange requirements, announced today the voting results for the election of directors at its Annual and Special Meeting of Shareholders held on May 10, 2018 in Toronto, Ontario.

A total of 16,723,457 common shares representing 62.5% of the Company's issued and outstanding common shares were represented at the meeting. Shareholders voted in favour of all items of business put forth at the meeting. The votes for the election of directors are as follows:

Nominee

% of Shares Voted For

% of Shares Voted Withhold

Dr. John Mull

98.56%

1.44%

Harold Wolkin

98.74%

1.26%

Christian Godin

98.25%

1.75%

Mark Beaudet

99.07%

0.93%

Arthur Deboeck

98.62%

1.38%

Robert Tessarolo

98.65%

1.35%

Dr. Laurence Terrisse-Rulleau

98.72%

1.28%

 

About Cipher Pharmaceuticals Inc.

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. Cipher is focused on a three-pronged growth strategy – including acquisitions, in-licensing, and selective investments in drug development – to assemble a broad portfolio of prescription products that serve unmet medical needs. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

PR Newswire
www.prnewswire.com

Last updated on: 11/05/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.